COLUMBIA LABORATORIES INC·4

Sep 16, 3:07 PM ET

MCGRANE MICHAEL 4

4 · COLUMBIA LABORATORIES INC · Filed Sep 16, 2010

Insider Transaction Report

Form 4
Period: 2010-09-15
MCGRANE MICHAEL
Senior VP & General Counsel
Transactions
  • Award

    Employee stock option (right to buy)

    2010-09-15$1.07/sh+150,000$160,500150,000 total
    Exercise: $1.07From: 2011-03-11Exp: 2017-09-15$0.01 par value common stock (150,000 underlying)
Footnotes (1)
  • [F1]25% of the grant vests on March 1, 2011, and each of the following three anniversaries of that date, provided, however, that 50% of unvested options will vest upon the acceptance by the US Food and Drug Administration of the Company's new drug application for the prevention of preterm birth.

Documents

2 files
  • 4
    doc1.xmlPrimary

    FORM 4

  • EX-24.1

    POWER OF ATTORNEY